Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

Göran Eriksson1 Department of Respiratory Medicine and Allergology, University Hospital, Lund, SwedenCorrespondence[email protected]

Peter M Calverley2 Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UK

Christine R Jenkins3 Concord Clinical School, University of Sydney;4 The George Institute for Global Health, Sydney, Australia

Antonio R Anzueto5 Department of Pulmonary Medicine and Critical Care, University of Texas Health Sciences Center and South Texas Veterans’ Health Care System, San Antonio, Texas

Barry J Make6 Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, Colorado, USA

Magnus Lindberg7 AstraZeneca R&D, Mölndal, Sweden

Malin Fagerås7 AstraZeneca R&D, Mölndal, Sweden

Dirkje S Postma8 Department of Pulmonary Medicine and Tuberculosis, University Medical Center Groningen, GRIAC Research Institute, University of Groningen, Groningen, the Netherlands

show all

Pages 1457-1468 | Published online: 15 May 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

FriedmanLFurbegCDemetsDFundamentals of Clinical Trials3rd edNew York, NYSpringer1998
Google Scholar
CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
PubMed Web of Science ®Google Scholar
CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet2003361935644945612583942
PubMed Web of Science ®Google Scholar
DransfieldMTBourbeauJJonesPWOnce-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trialsLancet Respir Med20131321022324429127
PubMed Web of Science ®Google Scholar
WiltTJNiewoehnerDMacDonaldRKaneRLManagement of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guidelineAnn Intern Med2007147963965317975187
PubMed Web of Science ®Google Scholar
SuissaSErnstPVandemheenKLAaronSDMethodological issues in therapeutic trials of COPDEur Respir J200831592793318216056
PubMed Web of Science ®Google Scholar
VestboJAndersonJACalverleyPMBias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH studyClin Respir J201151444921159140
PubMed Web of Science ®Google Scholar
CalverleyPMSpencerSWillitsLBurgePSJonesPWWithdrawal from treatment as an outcome in the ISOLDE study of COPDChest200312441350135614555565
PubMed Web of Science ®Google Scholar
KestenSPlautzMPiquetteCAHabibMPNiewoehnerDEPremature discontinuation of patients: a potential bias in COPD clinical trialsEur Respir J200730589890617690120
PubMed Web of Science ®Google Scholar
RennardSITashkinDPMcElhattanJEfficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trialDrugs200969554956519368417
PubMed Web of Science ®Google Scholar
SharafkhanehASouthardJGGoldmanMUryniakTMartinUJEffect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized studyRespir Med2012106225726822033040
PubMed Web of Science ®Google Scholar
TashkinDPRennardSIMartinPEfficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trialDrugs200868141975200018778120
PubMed Web of Science ®Google Scholar
GOLDGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease [updated; 2015. cited]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb18.pdf
Google Scholar
DecramerMMolenberghsGLiuDPremature discontinuation during the UPLIFT studyRespir Med2011105101523153021530213
PubMed Web of Science ®Google Scholar
JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
PubMed Web of Science ®Google Scholar
WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
PubMed Web of Science ®Google Scholar
DecramerMCelliBKestenSEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
PubMed Web of Science ®Google Scholar
WatzHTetzlaffKWoutersEFBlood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialLancet Respir Med20164539039827066739
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date